| 1 | androgen biosynthetic process (GO:0006702) | 8.54940102 |
| 2 | glucocorticoid metabolic process (GO:0008211) | 8.34653192 |
| 3 | amyloid precursor protein catabolic process (GO:0042987) | 8.15158138 |
| 4 | sexual reproduction (GO:0019953) | 7.65741571 |
| 5 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 7.25460475 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 6.87897512 |
| 7 | adhesion of symbiont to host (GO:0044406) | 6.46376309 |
| 8 | cellular response to gonadotropin stimulus (GO:0071371) | 6.40912302 |
| 9 | estrogen biosynthetic process (GO:0006703) | 6.11092282 |
| 10 | regulation of transforming growth factor beta2 production (GO:0032909) | 6.10420106 |
| 11 | growth hormone secretion (GO:0030252) | 5.96338969 |
| 12 | response to follicle-stimulating hormone (GO:0032354) | 5.76114401 |
| 13 | fibroblast migration (GO:0010761) | 5.73607379 |
| 14 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 5.50488043 |
| 15 | amyloid precursor protein metabolic process (GO:0042982) | 5.24603673 |
| 16 | sodium-independent organic anion transport (GO:0043252) | 4.93754835 |
| 17 | positive regulation of astrocyte differentiation (GO:0048711) | 4.75981779 |
| 18 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 4.75391012 |
| 19 | response to gonadotropin (GO:0034698) | 4.74057453 |
| 20 | cellular response to epinephrine stimulus (GO:0071872) | 4.72342582 |
| 21 | male genitalia development (GO:0030539) | 4.67950687 |
| 22 | phagocytosis, recognition (GO:0006910) | 4.56338026 |
| 23 | icosanoid transport (GO:0071715) | 4.55851916 |
| 24 | fatty acid derivative transport (GO:1901571) | 4.55851916 |
| 25 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 4.55427775 |
| 26 | hormone biosynthetic process (GO:0042446) | 4.49704510 |
| 27 | androgen metabolic process (GO:0008209) | 4.45443215 |
| 28 | hemoglobin metabolic process (GO:0020027) | 4.45371403 |
| 29 | endocrine hormone secretion (GO:0060986) | 4.43356174 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 4.42291658 |
| 31 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.36626125 |
| 32 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.36469137 |
| 33 | positive regulation of male gonad development (GO:2000020) | 4.35960299 |
| 34 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.19862686 |
| 35 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 4.18849343 |
| 36 | negative regulation of catenin import into nucleus (GO:0035414) | 4.15120260 |
| 37 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.14222273 |
| 38 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.12091947 |
| 39 | response to epinephrine (GO:0071871) | 4.01344532 |
| 40 | negative regulation of macrophage differentiation (GO:0045650) | 3.97933103 |
| 41 | regulation of gonadotropin secretion (GO:0032276) | 3.95678473 |
| 42 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.87228283 |
| 43 | regulation of cholesterol storage (GO:0010885) | 3.87132102 |
| 44 | sterol catabolic process (GO:0016127) | 3.85002748 |
| 45 | cholesterol catabolic process (GO:0006707) | 3.85002748 |
| 46 | regulation of cardioblast differentiation (GO:0051890) | 3.79788254 |
| 47 | cellular response to growth hormone stimulus (GO:0071378) | 3.79359670 |
| 48 | endothelial cell proliferation (GO:0001935) | 3.78598803 |
| 49 | endothelial cell chemotaxis (GO:0035767) | 3.75941858 |
| 50 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.66135734 |
| 51 | blood vessel endothelial cell migration (GO:0043534) | 3.60330161 |
| 52 | reproductive system development (GO:0061458) | 3.59937819 |
| 53 | cellular response to antibiotic (GO:0071236) | 3.59601216 |
| 54 | vitamin A metabolic process (GO:0006776) | 3.50578655 |
| 55 | regulation of male gonad development (GO:2000018) | 3.44001369 |
| 56 | prostaglandin metabolic process (GO:0006693) | 3.33780854 |
| 57 | prostanoid metabolic process (GO:0006692) | 3.33780854 |
| 58 | cellular response to cadmium ion (GO:0071276) | 3.29319113 |
| 59 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.19874274 |
| 60 | face development (GO:0060324) | 3.16218615 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.15667804 |
| 62 | regulation of triglyceride metabolic process (GO:0090207) | 3.11568166 |
| 63 | collecting duct development (GO:0072044) | 3.06146344 |
| 64 | DNA strand renaturation (GO:0000733) | 3.06030040 |
| 65 | positive regulation of steroid hormone secretion (GO:2000833) | 3.04059319 |
| 66 | nephron tubule formation (GO:0072079) | 3.01038858 |
| 67 | positive regulation of monooxygenase activity (GO:0032770) | 2.99768466 |
| 68 | organic cation transport (GO:0015695) | 2.99460685 |
| 69 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.94249169 |
| 70 | positive regulation of hormone metabolic process (GO:0032352) | 2.87866884 |
| 71 | reverse cholesterol transport (GO:0043691) | 2.87532027 |
| 72 | cellular response to interferon-alpha (GO:0035457) | 2.86750439 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 2.86701202 |
| 74 | progesterone metabolic process (GO:0042448) | 2.86066935 |
| 75 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.85533019 |
| 76 | negative regulation of fatty acid transport (GO:2000192) | 2.84410721 |
| 77 | substrate-dependent cell migration (GO:0006929) | 2.84172418 |
| 78 | cranial nerve structural organization (GO:0021604) | 2.81849554 |
| 79 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.81285726 |
| 80 | outflow tract septum morphogenesis (GO:0003148) | 2.80609250 |
| 81 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.78968369 |
| 82 | desmosome organization (GO:0002934) | 2.75981677 |
| 83 | cell volume homeostasis (GO:0006884) | 2.74930883 |
| 84 | drug transmembrane transport (GO:0006855) | 2.73404468 |
| 85 | cellular response to toxic substance (GO:0097237) | 2.69151120 |
| 86 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.65395214 |
| 87 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.63675632 |
| 88 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.61574230 |
| 89 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.60638397 |
| 90 | cellular response to dexamethasone stimulus (GO:0071549) | 2.59550864 |
| 91 | estrogen metabolic process (GO:0008210) | 2.59511255 |
| 92 | smooth muscle tissue development (GO:0048745) | 2.59382210 |
| 93 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.57897954 |
| 94 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.57647933 |
| 95 | actin filament depolymerization (GO:0030042) | 2.55258482 |
| 96 | steroid biosynthetic process (GO:0006694) | 2.54801562 |
| 97 | facial nerve structural organization (GO:0021612) | 2.54771653 |
| 98 | muscle hypertrophy in response to stress (GO:0003299) | 2.54063643 |
| 99 | cardiac muscle adaptation (GO:0014887) | 2.54063643 |
| 100 | glucocorticoid biosynthetic process (GO:0006704) | 10.8441322 |
C3ORF36 
